您当前的位置:

表观遗传学(epigenetics)是不改变DNA碱基序列,却能引发可遗传基因表达改变的调控方式,主要包括DNA甲基化、组蛋白修饰与非编码RNA调控三类机制。其中组蛋白修饰是在相关酶的催化下,发生甲基化、乙酰化、磷酸化、泛素化等共价修饰的生物学过程。组蛋白修饰通过改变组蛋白与双链DNA的结合亲和力,调控染色质呈松散或凝集状态,同时还可影响转录因子与结构基因启动子的结合能力,进而实现基因表达调控。依托组蛋白修饰可逆特性,HDAC、EZH2等靶向抑制剂已批准上市,成为表观靶向药物研发的重要方向。[1-3]

图1. 组蛋白甲基转移酶HMTs)和组蛋白去甲基化酶HDMs对自噬的表观调控[4]

靶向调控组蛋白甲基化修饰小分子:

 

图2. 组蛋白乙酰转移酶(HATs)与组蛋白去乙酰化酶(HDACs)对自噬的表观调控[4]

靶向调控组蛋白乙酰化修饰小分子:

参考文献:

[1] Shi Yuncong, et al. Epigenetic Regulation in Cardiovascular Disease: Mechanisms and Advances in Clinical Trials. Signal Transduction and Targeted Therapy, vol. 7, no. 1, 25 June 2022, p. 200.

[2] Dai Wanlin, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduction and Targeted Therapy, vol. 9, 2024, p. 332.

[3] Elizabeth A. Heller, et al. Epigenetic editing: from concept to clinic. Nature Reviews Drug Discovery, vol. 25, 2026, pp. 227–248.

[4] Seo Jieun, et al. Transcriptional and Epigenetic Regulation of Autophagy: Mechanisms, Disease Relevance and Therapeutic Opportunities. Signal Transduction and Targeted Therapy, vol. 11, 2026, p216.

 

 

上一篇:小分子课堂 | 表观遗传学信号通路DNA甲基化及相关小分子 下一篇:没有了